BY Advocate.com Editors
August 30 2002 12:00 AM ET
Cancer drug shows promise in treating K.S.
Phase II human trials of Bristol-Myers Squibb's anticancer drug paclitaxel--already approved to treat some cases of breast, ovarian, and lung cancers under the brand name Taxol--have shown that the drug is effective in treating advanced AIDS-related Kaposi's sarcoma, AIDS Policy & Law reports. The medication appears most useful in treating K.S. in patients who have failed other chemotherapy agents. The drug was evaluated in 107 male patients with advanced K.S. who had failed at least one previous regimen of systemic chemotherapy. More than half of the patients experienced a complete or partial response to the drug. Additional data from the clinical trial is expected to be released later this year. Phase III trials are planned.
- #TBT: The Battle for the Bulge
- The Cities LGBTs Love And the Ones We Shun
- Duggar Show Pulled From TLC Schedule, Could Be Canceled
- EXCLUSIVE: A Chat With Pop Legend Dionne Warwick and Her Granddaughter Cheyenne Elliott
- 25 Unforgettable Gay TV Kisses
- WATCH: Oregon Gov. Emotionally Signs Conversion Therapy Ban Into Law